Pore size regulates cell and tissue interactions with PLGA-CaP scaffolds used for bone engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 2, 2012, Pages 155-162

  Sicchieri, Luciana Gonçalves ^a   Crippa, Grasiele Edilaine ^a   de Oliveira, Paulo Tambasco ^a   Beloti, Marcio Mateus ^a   Rosa, Adalberto Luiz ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone tissue engineering; PLGA CaP; Pore size; Scaffold

Indexed keywords

BIOMATERIALS; BLOOD VESSELS; BONE; CALCIUM PHOSPHATE; CELL ENGINEERING; CELL GROWTH; GENE EXPRESSION; GROWTH KINETICS; OSTEOBLASTS; PHOSPHATASES; POLYMERASE CHAIN REACTION; RATS; SCAFFOLDS (BIOLOGY); STEM CELLS;

ALKALINE PHOSPHATASE ACTIVITY; BONE ENGINEERING; BONE TISSUE; BONE TISSUE ENGINEERING; CELL INTERACTION; GENES EXPRESSION; PLGA-CAP; PORE DIAMETERS; POROUS SCAFFOLD; TISSUE INTERACTIONS;

PORE SIZE;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BONE SIALOPROTEIN; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; OSTEOCALCIN; POLYGLACTIN; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE TISSUE; CALVARIA; CELL CULTURE; CELL GROWTH; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MALE; MORPHOMETRICS; NANOPORE; NONHUMAN; OSTEOBLAST; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TISSUE INTERACTION;

EID: 84856278757     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.422     Document Type: Article

References (32)

1. Anselme K, Bigerelle M. 2005; Topography effects of pure titanium substrates on human osteoblast long-term adhesion. Acta Biomater 1: 211-222.
2. Assis AF, Beloti MM, Crippa GE, et al. 2009; Development of the osteoblastic phenotype in human alveolar bone-derived cells grown on a collagen type I-coated titanium surface. Clin Oral Implants Res 20: 240-246.
3. Beloti MM, de Oliveira PT, Carvalho PSP, et al. 2009; Seeding osteoblastic cells into a macroporous biodegradable CaP/PLGA scaffold by a centrifugal force. J Biomater Appl 23: 481-495.
4. Boyan BD, Hummert TW, Dean DD, et al. 1996a; Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 17: 137-146.
5. Boyan BD, Sylvia VL, Dean DD, et al. 1996b; Cell biology of calcified tissues: experimental models of differentiation and mechanisms by which local and systemic factors exert their effects. Connect Tissue Res 35: 63-70.
6. Coelho MJ, Fernandes MH. 2000; Human bone cell cultures in biocompatibility testing. II. Effect of ascorbic acid, β-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21: 1095-1102.
7. Díaz-Flores L, Gutiérrez R, Madrid JF, et al. 2009; Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24: 909-969.
8. Eghbail-Fatourechi GZ, Lamsam J, Fraser D, et al. 2005; Circulating osteoblast-lineage cells in humans. N Engl J Med 352: 1959-1966.
9. Gauthier O, Bouler JM, Aguado E, et al. 1998; Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 19: 133-139.
10. Griffith LG, Naughton G. 2002; Tissue engineering-current challenges and expanding opportunities. Science 295: 1009-1014.
11. Guan L, Davies JE. 2004; Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold. J Biomed Mater Res 71A: 480-487.
12. Harley BA, Kim HD, Zaman MH, et al. 2008; Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions. Biophys J 95: 4013-4024.
13. Holy CE, Fialkov JA, Davies JE, et al. 2003; Use of a biomimetic strategy to engineer bone. J Biomed Mater Res 65A: 447-453.
14. Hutmacher DW, Schantz JT, Lam CX, et al. 2007; State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1: 245-260.
15. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474-5491.
16. Kasten P, Beyen I, Niemeyer P, et al. 2008; Porosity and pore size of β-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study. Acta Biomater 4: 1904-1915.
17. Kim K, Yeatts A, Dean D, et al. 2010; Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng 29: 1-17.
18. Kuboki Y, Jin Q, Takita H. 2001; Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Join Surg Am 83 S1: S105-115.
19. Langer R, Vacanti JP. 1993; Tissue engineering. Science 260: 920-926.
20. Lian J, Stein G. 1992; Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 3: 269-305.
21. Lickorish D, Chan J, Song J, et al. 2004; An in vivo model to interrogate the transition from acute to chronic inflammation. Eur J Cells Mat 13: 12-20.
22. Lickorish D, Guan L, Davies JE. 2007; A three-phase, fully resorbable, polyester/calcium phosphate scaffold for bone tissue engineering: evolution of scaffold design. Biomaterials 28: 1495-1502.
23. 2 - ΔΔCT method. Methods 25: 402-408.
24. Logeart-Avramoglou D, Anagnostou F, Bizios R, et al. 2005; Engineering bone: challenges and obstacles. J Cell Mol Med 9: 72-84.
25. Maniatopoulos C, Sodek J, Melcher AH. 1988; Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254: 317-330.
26. Mosmann T. 1983; Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 16: 55-63.
27. Prockop DJ. 1997; Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
28. Roosa SM, Kemppainen JM, Moffitt EN, et al. 2010; The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res 92: 359-368.
29. Rosa AL, Beloti MM. 2003; Effect of cpTi surface roughness on human bone marrow cell attachment, proliferation, and differentiation. Braz Dent J 14: 16-21.
30. Sittinger M, Bujia J, Rotter N, et al. 1996; Tissue engineering and autologous transplant formation: practical approaches with resorbable biomaterials and new cell culture techniques. Biomaterials 17: 237-42.
31. Tsuruga E, Takita H, Itoh H, et al. 1997; Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 121: 317-324.
32. Villars F, Bordenave L, Bareille R, et al. 2000; Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell Biochem 79: 672-685.